Quantamental Technologies LLC Coherus Bio Sciences, Inc. Transaction History
Quantamental Technologies LLC
- $105 Million
- Q3 2023
A detailed history of Quantamental Technologies LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Quantamental Technologies LLC holds 10,329 shares of CHRS stock, worth $16,629. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,329Holding current value
$16,629% of portfolio
0.04%Shares
6 transactions
Others Institutions Holding CHRS
# of Institutions
148Shares Held
82.9MCall Options Held
184KPut Options Held
255K-
Black Rock Inc. New York, NY11.2MShares$18.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$16.7 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$16.2 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U07.38MShares$11.9 Million0.1% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$4.89 Million0.31% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $125M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...